cefaclor anhydrous has been researched along with Pneumonia in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (56.52) | 18.7374 |
| 1990's | 9 (39.13) | 18.2507 |
| 2000's | 1 (4.35) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leuenberger, P; Vrantchev, S | 1 |
| Hiraga, Y; Kikuchi, K; Yamamoto, A | 1 |
| Iancu, TC; Sinoff, G | 1 |
| Grassi, GG | 1 |
| Dubois, J; Fong, IW; Grossman, R; Laforge, J; Small, D; Zakhari, R | 1 |
| Ball, P | 1 |
| McCabe, R; Mogabgab, W; Perrotta, R; Rumans, L | 1 |
| Goss, TF; Najib, MM; Stein, GE | 1 |
| Beville, RB; Gentry, LO; Jemsek, JG; Mogabgab, WJ; Pollock, B | 1 |
| Clavel, A; Espinosa, C; Gómez-Agudo, G; Gómez-Lus, R; Guillen, G; Martinez-Piriz, R | 1 |
| Laitinen, L; Mattson, K; Nikander-Hurme, R; Renkonen, OV | 1 |
| Gatzemeier, U; Simon, C | 1 |
| Thornsberry, C | 1 |
| Delacourt, C; Paupe, J; Sarbeji, M; Scheinmann, P; Sorin, M | 1 |
| Dark, D | 1 |
| Kinasewitz, G; Wood, RG | 1 |
| Gomi, K; Hiraga, Y; Konishi, K; Nakayama, I; Ohmichi, M; Oizumi, K; Saito, A; Tamura, M; Tomizawa, M; Watanabe, A | 1 |
| Miyahara, T; Nakayama, I; Onodera, S; Saito, A; Sasaki, N; Shiba, K; Shimada, J; Tamura, M; Tomizawa, M | 1 |
| Kamimura, T; Kikuchi, H; Kuwahara, S; Mine, Y; Shibayama, F; Tawara, S; Wakai, Y; Yokota, Y | 1 |
| Anthony, WC; Craig, W; File, TM; Lifland, P; Schleupner, CJ; Tan, J; Vogelman, B | 1 |
| Chimoto, T; Ikeda, Y; Ishii, Y; Nakabayashi, T; Onodera, S; Sasaki, N; Shibaki, H; Shimizu, T; Tosaka, M; Watanabe, H | 1 |
| Bonner, DP; Clark, JM; Dalvi, M; Olsen, SJ; Sykes, RB; Weinberg, DS; Whitney, RR | 1 |
| Catchpole, M; Gentry, L; Koornhof, H; Lowe, P; ZeLuff, B | 1 |
2 review(s) available for cefaclor anhydrous and Pneumonia
| Article | Year |
|---|---|
Comparative clinical efficacy of cefetamet pivoxil in lower respiratory tract infection.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Cefaclor; Ceftizoxime; Child; Dose-Response Relationship, Drug; Female; Humans; Male; Pneumonia; Respiratory Tract Infections | 1994 |
Efficacy and safety of cefprozil versus other beta-lactam antibiotics in the treatment of lower respiratory tract infections.
Topics: Adolescent; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Cefaclor; Cefprozil; Cefuroxime; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Male; Multicenter Studies as Topic; Pneumonia; Prodrugs; Randomized Controlled Trials as Topic; Respiratory Tract Infections | 1994 |
13 trial(s) available for cefaclor anhydrous and Pneumonia
| Article | Year |
|---|---|
Cefaclor versus amoxicillin in the treatment of bacterial pneumonia: a comparative double-blind study.
Topics: Adult; Amoxicillin; Bacteria; Cefaclor; Cephalexin; Clinical Trials as Topic; Double-Blind Method; Humans; Microbial Sensitivity Tests; Pneumonia | 1983 |
Clarithromycin versus cefaclor in lower respiratory tract infections. The Canadian Bronchitis Study Group.
Topics: Bronchitis; Cefaclor; Clarithromycin; Female; Haemophilus influenzae; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Pneumonia; Streptococcus pneumoniae | 1995 |
Efficacy and safety of cefprozil versus other beta-lactam antibiotics in the treatment of lower respiratory tract infections.
Topics: Adolescent; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Cefaclor; Cefprozil; Cefuroxime; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Male; Multicenter Studies as Topic; Pneumonia; Prodrugs; Randomized Controlled Trials as Topic; Respiratory Tract Infections | 1994 |
Treatment of acute bronchitis and pneumonia with cefaclor.
Topics: Acute Disease; Bacteria; Bronchitis; Cefaclor; Cephalexin; Clinical Trials as Topic; Drug Administration Schedule; Humans; Pneumonia; Sputum | 1979 |
Serum and sputum levels of cefaclor.
Topics: Adult; Bronchial Neoplasms; Bronchitis; Cefaclor; Cephalexin; Humans; Intestinal Absorption; Male; Middle Aged; Pneumonia; Sputum; Time Factors | 1979 |
Clinical trials on pediatric lower-respiratory-tract infection: results and comments with cefetamet pivoxil.
Topics: Bacterial Infections; Bronchitis; Bronchopneumonia; Cefaclor; Ceftizoxime; Child; Child, Preschool; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Male; Pneumonia; Respiratory Tract Infections; Staphylococcal Infections; Streptococcal Infections | 1992 |
Multicenter evaluation of azithromycin and cefaclor in acute lower respiratory tract infections.
Topics: Azithromycin; Bronchitis; Cefaclor; Erythromycin; Haemophilus Infections; Humans; Klebsiella Infections; Moraxella catarrhalis; Neisseriaceae Infections; Pneumonia; Prospective Studies; Sputum; Staphylococcal Infections; Streptococcal Infections | 1991 |
Azithromycin versus cefaclor in the treatment of acute bacterial pneumonia.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Azithromycin; Bacterial Infections; Cefaclor; Double-Blind Method; Drug Administration Schedule; Erythromycin; Female; Humans; Male; Middle Aged; Pneumonia | 1991 |
[Clinical evaluation of BMY-28100 for bacterial pneumonia in comparison with cefaclor in a double-blind study].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefaclor; Cefprozil; Cephalosporins; Double-Blind Method; Female; Humans; Male; Middle Aged; Pneumonia | 1990 |
[Comparative clinical study of CS-807 and cefaclor for bacterial pneumonia by a double-blind method].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefaclor; Cefpodoxime Proxetil; Ceftizoxime; Cephalexin; Cephalosporins; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Pneumonia | 1988 |
Blinded comparison of cefuroxime to cefaclor for lower respiratory tract infections.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Bacterial Infections; Bronchitis; Cefaclor; Cefuroxime; Cephalexin; Cephalosporins; Clinical Trials as Topic; Drug Therapy; Female; Humans; Male; Middle Aged; Pneumonia; Prodrugs; Random Allocation; Respiratory Tract Infections | 1988 |
[A double blind comparative study on the efficacy of S6472, cefaclor and amoxicillin, in the treatment of bacterial pneumonia].
Topics: Adolescent; Adult; Aged; Amoxicillin; Bacterial Infections; Cefaclor; Cephalexin; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Lung Abscess; Male; Middle Aged; Pneumonia | 1986 |
Cefadroxil compared with cefaclor in the treatment of streptococcal pneumonia in adults.
Topics: Adult; Cefaclor; Cefadroxil; Cephalexin; Female; Humans; Male; Middle Aged; Pneumonia; Streptococcal Infections | 1986 |
9 other study(ies) available for cefaclor anhydrous and Pneumonia
| Article | Year |
|---|---|
[Clinical studies of cefaclor for respiratory tract infections].
Topics: Acute Disease; Administration, Oral; Adult; Aged; Cefaclor; Cephalexin; Drug Evaluation; Female; Humans; Male; Middle Aged; Pneumonia | 1984 |
Therapy of acute bacterial infections with cefaclor in a pediatric population: an open assessment.
Topics: Acute Disease; Bacterial Infections; Cefaclor; Cephalexin; Child; Child, Preschool; Female; Humans; Infant; Male; Otitis Media; Pneumonia; Respiratory Tract Infections | 1983 |
Comparison of the efficacy and safety of ceftibuten and cefaclor in the treatment of pneumonia and bronchiectasis.
Topics: Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Bronchiectasis; Cefaclor; Ceftibuten; Cephalosporins; Female; Humans; Male; Middle Aged; Pneumonia | 1993 |
Cost-effectiveness of sparfloxacin compared with other oral antimicrobials in outpatient treatment of community-acquired pneumonia.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Azithromycin; Cefaclor; Clarithromycin; Community-Acquired Infections; Cost-Benefit Analysis; Erythromycin; Fluoroquinolones; Humans; Models, Economic; Outpatients; Pneumonia; Treatment Outcome | 2000 |
Treatment of acute bacterial bronchitis and pneumonia with cefaclor.
Topics: Acute Disease; Adolescent; Adult; Aged; Bronchitis; Cefaclor; Cephalexin; Child; Drug Administration Schedule; Haemophilus influenzae; Humans; Male; Middle Aged; Pneumonia; Sputum; Streptococcus pneumoniae | 1979 |
Cefaclor: clinical and bacteriological evaluation in 45 cases.
Topics: Adult; Aged; Cefaclor; Cephalexin; Enterobacteriaceae; Female; Humans; Male; Middle Aged; Pneumonia; Staphylococcus aureus; Streptococcus pneumoniae; Urinary Tract Infections | 1979 |
Cefaclor AF: correlation of microbiology and clinical outcome.
Topics: Bronchitis; Cefaclor; Chemistry, Pharmaceutical; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Neisseriaceae Infections; Pneumonia; Skin Diseases, Bacterial; Urinary Tract Infections | 1992 |
In vivo antibacterial activity of FK482, a new orally active cephalosporin.
Topics: Administration, Oral; Animals; Bacterial Infections; Cefaclor; Cefdinir; Cephalosporins; Male; Mice; Mice, Inbred ICR; Pneumonia; Pyelonephritis; Rabbits | 1988 |
In vivo evaluation of tigemonam, a novel oral monobactam.
Topics: Acute Disease; Administration, Oral; Amoxicillin; Animals; Bacterial Infections; Cefaclor; Cephalexin; Dogs; Enterobacteriaceae Infections; Female; Kinetics; Klebsiella pneumoniae; Male; Mice; Monobactams; Pneumonia; Pyelonephritis; Rats; Rats, Inbred Strains | 1987 |